Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

CYCN Stock Annual Income Statement. Download in Excel

Cyclerion Therapeutics Inc. logo

Cyclerion Therapeutics Inc.

Sector: Healthcare   

Industry: Biotechnology

3.57
 
USD
  
-0.13
  
(-3.51%)
Previous close: 3.7  Open: 3.53  Bid: 3.57  Ask: 3.67
52 week range    
1.27   
   9.47
Mkt Cap: 11 M  Avg Vol (90 Days): 3,495,990
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Friday 13th December 2024

Stock Rankings

80
Value
42
Quality
How are these ranks calculated?
Ad slot not ready
Search for a stock

Financials

CYCN Income Statement

Annual
Invalid dateDec-19Dec-20Dec-21Dec-22Dec-23
Basic EPS from continuing operations-51.2-26.4-20.2-7.64
Basic EPS total-51.2-26.4-20.2-2.25
Basic weighted shares outstanding1369.02 M2 M2 M2 M
BasicDiscontinuousOperations3.14
Depreciation2 M472000.065000.0
Depreciation unreconciled-3 M
DepreciationAndAmortization-3 M2 M472000.065000.0
Diluted EPS total-89.8-51.2-26.4-20.2-2.25
Diluted normalized net income/share-20.2-7.64
Diluted weighted shares outstanding1 M2 M2 M2 M
DilutedDiscontinuousOperations3.14
GainOnSaleOfPPE-751000.0159000.0-881000.0
GainOnSaleOfSecurity2 M588000.0
GeneralAndAdministrativeExpense34 M29 M21 M13 M8 M
Gross operating profit5 M2 M4 M297000.0
ImpairmentOfCapitalAssets3 M
Income before tax-123 M-84 M-52 M-18 M-13 M
Income restructuring and M&A-1 M-565000.0
Income taxes-10 M-6 M-4 M-3 M-5000.0
InterestExpenseNonOperating16000.0
MiscOtherSpecialCharges588000.04 M294000.0358000.0
Net income from total operations-123 M-78 M-52 M-44 M-5 M
NetIncomeCommonStockholders-123 M-78 M-52 M-44 M-5 M
NetIncomeContinuousOperations-123 M-78 M-52 M-18 M-13 M
NetIncomeDiscontinuousOperations-26 M7 M
NetIncomeFromOtherGainsLosses3 M
NetNonOperatingInterestIncomeExpense-294000.0-358000.0
Normalized income-54 M-10 M
Operating income-125 M-81 M-55 M-19 M-13 M
Operating income before depreciation (EBITDA)-120 M-81 M-54 M-18 M-10 M
OperatingExpense-130 M84 M59 M19 M10 M
Other income net-2 M-588000.0-3 M-294000.0-3 M
OtherGainLossFromDispositionOfDiscontinuedOperations-26 M7 M
OtherGandA34 M29 M21 M13 M8 M
OtherOperatingExpenses-130 M2 M-881000.019 M13 M
RentAndLandingFees34 M
Research & development expense95 M56 M38 M6 M2 M
ResearchExpense95 M56 M38 M6 M2 M
RestructringAndMnAIncome-1 M-565000.0
SalariesAndWages-20 M100000.0
Selling Gen & administrative expense34 M29 M21 M13 M8 M
Special income/charges1 M-3 M
Total Income available for interest expense (EBIT)-123 M-83 M-54 M-19 M-10 M
Total common shares outstanding1 M2 M2 M2 M3 M
Total net income-123 M-78 M-52 M-44 M-5 M
Total ordinary shares3 M3 M3 M3 M3 M
Total revenues5 M2 M4 M297000.0
TotalExpenses-130 M84 M59 M19 M10 M
TotalRevenue5 M2 M4 M297000.0
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University